Cargando…
Brief recommendations on the management of adult patients with familial hypercholesterolemia during the COVID-19 pandemic
Individuals with Familial Hypercholesterolaemia (FH) are at very high risk of cardiovascular disease, which is associated with poor outcomes from coronavirus infections. COVID-19 puts strain on healthcare systems and may impair access to routine FH services. On behalf of the International Lipid Expe...
Autores principales: | Banach, Maciej, Penson, Peter E., Fras, Zlatko, Vrablik, Michal, Pella, Daniel, Reiner, Željko, Nabavi, Seyed Mohammad, Sahebkar, Amirhossein, Kayikcioglu, Meral, Daccord, Magdalena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204727/ https://www.ncbi.nlm.nih.gov/pubmed/32389859 http://dx.doi.org/10.1016/j.phrs.2020.104891 |
Ejemplares similares
-
Personalized management of dyslipidemias in patients with diabetes—it is time for a new approach (2022)
por: Banach, Maciej, et al.
Publicado: (2022) -
Pulse wave velocity as a measure of arterial stiffness in patients with familial hypercholesterolemia: a systematic review and meta-analysis
por: Reiner, Željko, et al.
Publicado: (2019) -
MicroRNAs: New Therapeutic Targets for Familial Hypercholesterolemia?
por: Momtazi, Amir Abbas, et al.
Publicado: (2017) -
Current Treatment Options in Homozygous Familial Hypercholesterolemia
por: Kayikcioglu, Meral, et al.
Publicado: (2022) -
2022: the year in cardiovascular disease – the year of upfront lipid lowering combination therapy
por: Banach, Maciej, et al.
Publicado: (2022)